OBJECTIVE
To increase awareness concerning abdominal pain asociated with the use of captopril, which is a molecule frequently used in diabetic patients.
CASE:— One case of acute pancreatitis associated with captopril, confirmed by a reintroduction, is described in a type II diabetes patient.
CONCLUSIONS
Captopril and other angiotensin-converting enzyme inhibitors are very frequently prescribed in diabetic patients. Therefore, it is important to be aware of the possibility of pancreatitis linked to these molecules and to withdraw the treatment in case of severe unexplained abdominal pain.
This content is only available via PDF.
Copyright © 1995 by the American Diabetes Association
1995